← Leaderboards
Drew James Adams
Case Western Reserve University
$4,187,450
Attributed
$4,187,450
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,187,450 · 6
By mechanism
R01$3,531,607 · 2
P30$655,843 · 4
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Amitabh Chak$17,077,792
- Katrina A Goddard$14,648,102
- Kishore Guda$5,264,331
- Siran M. Koroukian$1,875,804
- You-Wei Zhang$6,414,867
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoPharmaceutical ChemistryResearch PersonnelHigh Throughput ScreeningScreeningSmall MoleculeIn VitroLibrariesFutureDrug DevelopmentIn Vivo EvaluationSmall Molecule LibrariesInnovationPathway InteractionsLeadPharmacologyDrug DiscoveryBiologyClinicComprehensive Cancer CenterDrug TargetingAutomationCheminformaticsConsultations
Grant awards (17)
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation$498,038
R01 · FY2025 · AI · contact PI
Small Molecule Drug Development$84,610
P30 · FY2025 · CA · contact PI
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation$518,271
R01 · FY2024 · AI · contact PI
New sterol-binding targets and optimized EBP inhibitors for promoting remyelination$381,046
R01 · FY2024 · NS · contact PI
Small Molecule Drug Development Shared Resource$85,195
P30 · FY2024 · CA · contact PI
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation$510,221
R01 · FY2023 · AI · contact PI
New sterol-binding targets and optimized EBP inhibitors for promoting remyelination$404,785
R01 · FY2023 · NS · contact PI
Small Molecule Drug Development Shared Resource$85,195
P30 · FY2023 · CA · contact PI
New sterol-binding targets and optimized EBP inhibitors for promoting remyelination$404,785
R01 · FY2022 · NS · contact PI
Small Molecule Drug Development Shared Resource$81,250
P30 · FY2022 · CA · contact PI
New sterol-binding targets and optimized EBP inhibitors for promoting remyelination$407,441
R01 · FY2021 · NS · contact PI
Small Molecule Drug Development Shared Resource$79,603
P30 · FY2021 · CA · contact PI
New sterol-binding targets and optimized EBP inhibitors for promoting remyelination$407,020
R01 · FY2020 · NS · contact PI
Small Molecule Drug Development Shared Resource$77,814
P30 · FY2020 · CA · contact PI
Small Molecule Drug Development Shared Resource$75,468
P30 · FY2019 · CA · contact PI
Small Molecule Drug Development Shared Resource$77,450
P30 · FY2018 · CA · contact PI
Small Molecule Drug Development Shared Resource$9,258
P30 · FY2018 · CA · contact PI